Methyl Imidazo[1,2-a]pyridine-6-carboxylate, 95.0%, 25g

(3aR,5R,6S,6aR)-5-(((tert-Butyldiphenylsilyl)oxy)methyl)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-6-ol, 95%, 100mg

Ethyl 5-amino-1-(3-chlorophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 2g

(S)-TERT-BUTYL 2-(METHOXY(METHYL)CARBAMOYL)PIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

CIS-(2-PHENYLCYCLOPROPYL)METHANOL, 95.0%, 1g

N-[1-(1H-1,2,3-Benzotriazol-1-yl)-2-methylpropyl]-4-methylbenzene-1-sulfonamide, tech, 50mg

N,N-Dimethyl-2-nitro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 1g

9-Methyl-9H-fluoren-9-ol>98.0%(GC)1g

Methyl hydrazinecarbimidothioate hydroiodide, 95.0%, 10g

EDC-HCI, PEPTIPURE®, mínimo 99 %, 5 g, envase de vidrio

N,N-Dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)picolinamide, 95.0%, 25g

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate, 98%, 100mg

Objetivo E-plan EPL S40x/0,65